UnitedHealth Group Financial Statements (UNH) |
||||||||||
UnitedHealth Groupsmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 01.03.2021 | 15.02.2022 | 31.12.2022 | 24.02.2023 | 31.12.2023 | 04.11.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 255 639 | 285 273 | 324 162 | 322 132 | 371 622 | 400 291 | |||
Operating Income, bln rub | 22 405 | 23 970 | 28 435 | 28 435 | 32 358 | 33 222 | ||||
EBITDA, bln rub | ? | 25 296 | 27 073 | 31 316 | 31 835 | 36 330 | 23 164 | |||
Net profit, bln rub | ? | 15 403 | 17 285 | 20 120 | 20 120 | 22 381 | 14 917 | |||
OCF, bln rub | ? | 22 174 | 22 343 | 26 206 | 26 206 | 29 068 | 35 780 | |||
CAPEX, bln rub | ? | 2 051 | 2 454 | 2 802 | 2 802 | 3 386 | 3 578 | |||
FCF, bln rub | ? | 20 123 | 19 889 | 23 404 | 23 404 | 25 682 | 32 202 | |||
Dividend payout, bln rub | 4 584 | 5 280 | 5 991 | 5 991 | 6 761 | 7 538 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
Dividend payout ratio, % | 29.8% | 30.5% | 29.8% | 29.8% | 30.2% | 50.5% | ||||
OPEX, bln rub | 44 595 | 45 682 | 84 885 | 51 182 | 339 264 | 134 648 | ||||
Cost of production, bln rub | 190 141 | 217 945 | 210 842 | 244 545 | 284 753 | 414 563 | ||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Interest expenses, bln rub | 1 663 | 1 660 | 2 092 | 2 092 | 3 246 | 7 635 | ||||
Assets, bln rub | 197 289 | 212 206 | 245 705 | 245 705 | 278 415 | 299 309 | ||||
Net Assets, bln rub | ? | 65 491 | 71 760 | 0.000 | 77 772 | 88 756 | 99 881 | |||
Debt, bln rub | 43 467 | 46 003 | 57 623 | 57 623 | 67 435 | 78 010 | ||||
Cash, bln rub | 19 781 | 23 907 | 55 822 | 27 911 | 29 628 | 37 134 | ||||
Net debt, bln rub | 23 686 | 22 096 | 1 801 | 29 712 | 37 807 | 40 876 | ||||
Ordinary share price, rub | 350.7 | 502.1 | 530.2 | 530.2 | 526.5 | 537.0 | ||||
Number of ordinary shares, mln | 946.0 | 943.0 | 950.0 | 934.0 | 928.0 | 923.0 | ||||
Market cap, bln rub | 331 743 | 473 518 | 503 671 | 495 188 | 488 564 | 495 651 | ||||
EV, bln rub | ? | 355 429 | 495 614 | 505 472 | 524 900 | 526 371 | 536 527 | |||
Book value, bln rub | -16 702 | -14 079 | 0 | -29 981 | -30 170 | -29 691 | ||||
EPS, rub | ? | 16.3 | 18.3 | 21.2 | 21.5 | 24.1 | 16.2 | |||
FCF/share, rub | 21.3 | 21.1 | 24.6 | 25.1 | 27.7 | 34.9 | ||||
BV/share, rub | -17.7 | -14.9 | 0.00 | -32.1 | -32.5 | -32.2 | ||||
EBITDA margin, % | ? | 9.90% | 9.49% | 9.66% | 9.88% | 9.78% | 5.79% | |||
Net margin, % | ? | 6.03% | 6.06% | 6.21% | 6.25% | 6.02% | 3.73% | |||
FCF yield, % | ? | 6.07% | 4.20% | 4.65% | 4.73% | 5.26% | 6.50% | |||
ROE, % | ? | 23.5% | 24.1% | 25.9% | 25.2% | 14.9% | ||||
ROA, % | ? | 7.81% | 8.15% | 8.19% | 8.19% | 8.04% | 4.98% | |||
P/E | ? | 21.5 | 27.4 | 25.0 | 24.6 | 21.8 | 33.2 | |||
P/FCF | 16.5 | 23.8 | 21.5 | 21.2 | 19.0 | 15.4 | ||||
P/S | ? | 1.30 | 1.66 | 1.55 | 1.54 | 1.31 | 1.24 | |||
P/BV | ? | -19.9 | -33.6 | -16.5 | -16.2 | -16.7 | ||||
EV/EBITDA | ? | 14.1 | 18.3 | 16.1 | 16.5 | 14.5 | 23.2 | |||
Debt/EBITDA | 0.94 | 0.82 | 0.06 | 0.93 | 1.04 | 1.76 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
CAPEX/Revenue, % | 0.80% | 0.86% | 0.86% | 0.87% | 0.91% | 0.89% | ||||
UnitedHealth Group shareholders |